Evidence map›Paper›PMID 40671087›Full record

ArticleJournal of cardiothoracic surgery2025

Primary cardiac diffuse large B-cell lymphoma patient: clinical, histologic, immunophenotypic feature and a novel surgical technology: a case report.

Chenxi Ying, Weidong Li, Yu Zou, Bohao Dai, Xin Chen

Abstract readCase Reports
In one paragraph

Article in Journal of cardiothoracic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chenxi YingDepartment of Cardiovascular Surgery, The First Affiliated Hospital Zhejiang University of Medicine, 79 Qingchun Road, Shangcheng District, Hangzhou City, Zhejiang Province, China.
Weidong LiDepartment of Cardiovascular Surgery, The First Affiliated Hospital Zhejiang University of Medicine, 79 Qingchun Road, Shangcheng District, Hangzhou City, Zhejiang Province, China.
Yu ZouDepartment of Cardiovascular Surgery, The First Affiliated Hospital Zhejiang University of Medicine, 79 Qingchun Road, Shangcheng District, Hangzhou City, Zhejiang Province, China.
Bohao DaiDepartment of Cardiovascular Surgery, The First Affiliated Hospital Zhejiang University of Medicine, 79 Qingchun Road, Shangcheng District, Hangzhou City, Zhejiang Province, China.
Xin ChenDepartment of Cardiovascular Surgery, The First Affiliated Hospital Zhejiang University of Medicine, 79 Qingchun Road, Shangcheng District, Hangzhou City, Zhejiang Province, China. chenxin0131@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary cardiac lymphoma (PCL) is a rare malignancy, representing a small fraction of primary cardiac tumors. Non-germinal center B-cell (non-GCB) diffuse large B-cell lymphoma (DLBCL), a subtype of PCL, often presents with severe symptoms due to its cardiac involvement, and poses diagnostic and therapeutic challenges. This case highlights the use of an innovative surgical approach in managing a non-GCB primary cardiac DLBCL. CASE PRESENTATION: We report the case of a 68-year-old woman presenting with palpitations, dizziness, and obstructive cardiac symptoms. Diagnostic imaging revealed a large mass in the right atrium near the superior vena cava. A novel "zongzi"-shaped endoscopic gauze folding technique was employed to facilitate complete tumor resection while preserving cardiac structure. Pathology confirmed double expressor DLBCL with BCL2 and MYC co-expression, indicating a high-risk profile. The patient's postoperative course was uneventful, and she was discharged in stable condition. However, follow-up imaging at six months revealed local disease progression.

conclusionsThis case underscores the challenges in managing primary cardiac DLBCL and highlights the potential of novel surgical techniques to improve resection outcomes while minimizing structural damage to the heart. Further research is essential to optimize multimodal approaches, particularly for aggressive PCL subtypes like double expressor lymphoma.

Indexed as

Cardiac Surgical ProceduresHeart NeoplasmsLymphoma, Large B-Cell, DiffuseAgedFemaleHeart AtriaHumansImmunophenotypingDiffuse large B-cell lymphomaDouble expressor lymphomanon-GCBNovel surgical technologyPrimary cardiac tumor

Identifiers

PMID40671087
PMCPMC12265133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.